Rafferty Asset Management, LLC Eye Point Pharmaceuticals, Inc. Transaction History
Rafferty Asset Management, LLC
- $26.8 Billion
- Q2 2024
A detailed history of Rafferty Asset Management, LLC transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 10,514 shares of EYPT stock, worth $83,901. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,514
Previous 12,102
13.12%
Holding current value
$83,901
Previous $250,000
63.6%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding EYPT
# of Institutions
163Shares Held
58.2MCall Options Held
224KPut Options Held
1.41M-
Cormorant Asset Management, LP Boston, MA8.33MShares$66.4 Million5.57% of portfolio
-
Suvretta Capital Management, LLC New York, NY5.18MShares$41.3 Million1.88% of portfolio
-
Black Rock Inc. New York, NY3.76MShares$30 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA3.65MShares$29.1 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.59MShares$28.7 Million0.06% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $272M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...